Sgx Pharmaceuticals Inc: Premium Company Profile

Publication Date	December 2007
Publisher	Datamonitor
Product Type	Databook
Pages	49
ISBN Number	not applicable
Product Code	DAT09438

Price

£265.00
approximately: $495 | €336

PRINT £265 ($495 | €336)

Order above formats by FAX

Summary

Introduction

SGX Pharmaceuticals's main focus is to discover, develop and commercialize products for the treatment of diseases in the therapeutic area of oncology. The company seeks to build a franchise of oncology products through its own internal efforts as well as partnering with other pharmaceutical companies to develop and commercialize innovative cancer therapeutics.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

SGX Pharmaceuticals has two programs in discovery stage, namely, JAK2 inhibitor and RAS inhibitor, for the treatment of myeloproliferative disorders and solid tumors respectively. SGX-523, which is in the preclinical stage, is an oral small molecule kinase inhibitor indicated for the treatment of solid tumors.

SGX Pharmaceuticals derives its revenues mainly from collaboration, commercial agreement and grants received on various contractual agreements with pharmaceutical and biotechnology companies such as Novartis and Cystic Fibrosis Foundation Therapeutics, as well as government and other agencies. The company does not have any marketed product.

SGX Pharmaceuticals's biggest contributor to sales growth out to 2010 will be collaboration and commercial agreements stream, which would be recognized in connection with the collaboration and commercial agreements with Novartis and Cystic Fibrosis Foundation Therapeutics.

Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

Overview
Catalyst
- Summary
- Company Structure
- Company Overview and Key Facts
- Business Description
- History
- Locations and Subsidiaries
- Company Financials
- Stock Market Performance
- P&L
- Balance Sheet
- Cash Flow
- Business Segment Performance
- Products & Services
- Pipeline Products
- AC Forecast Product Sales
- Competitors and Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Overview
- Discovery and Product Development
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
- List of Key Employees
- Key Employee Biographies
- Financial and Operational Overview
- Financial and Operational Overview
Appendix
- Ask the analyst
- Datamonitor consulting
- Disclaimer
- Figure 1: SGX Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 1: SGX Pharmaceuticals - Key Facts
- Table 2: SGX Pharmaceuticals - Other Locations and Subsidiaries
- Table 3: SGX Pharmaceuticals - Year-End Share Price and Market Capitalization, 2002-2006 ($)
- Table 4: SGX Pharmaceuticals - Key Events Impacting Share Price Performance
- Table 5: SGX Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 6: SGX Pharmaceuticals - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
- Table 7: SGX Pharmaceuticals - Balance Sheet, 2002-2006 ($ Mn)
- Table 8: SGX Pharmaceuticals - Cash Flow, 2002-2006 ($ Mn)
- Table 9: SGX Pharmaceuticals - Revenue Breakdown, 2002-2006 ($ Mn)
- Table 10: SGX Pharmaceuticals - in-house Pipeline Products
- Table 11: SGX Pharmaceuticals - Collaboration Pipeline Products
- Table 12: SGX Pharmaceuticals - Forecast Sales, 2006-2010 ($ Mn)
- Table 13: SGX Pharmaceuticals - Key Competitors
- Table 14: SGX Pharmaceuticals - Key Suppliers
- Table 15: SGX Pharmaceuticals - Key Clients
- Table 16: SGX Pharmaceuticals - Key Shareholders
- Table 17: SGX Pharmaceuticals - SWOT Analysis Summary
- Table 18: SGX Pharmaceuticals - Value Chain Analysis
- Table 19: SGX Pharmaceuticals - Scorecard
- Table 20: SGX Pharmaceuticals - Key Employees
- Table 21: SGX Pharmaceuticals - Financial and Operational Overview